The Food and Drug Administration yesterday approved the first generic version of Symbicort, a metered-dose inhaler for asthma and chronic obstructive pulmonary disease.

“Today’s approval of the first generic for one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD is another step forward in our commitment to bring generic copies of complex drugs to the market, which can improve quality of life and help reduce the cost of treatment,” said Sally Choe, director of FDA’s Office of Generic Drugs.
 

Related News Articles

Headline
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…
Headline
The Food and Drug Administration this week alerted health care providers to a shortage of tracheostomy tubes, used to help people breathe after a…
Headline
Exela Pharma Sciences this week recalled 49 lots of sodium bicarbonate injection because the vial may break while preparing the product for administration…
Headline
Covidien LLC (Medtronic) recently recalled more than 1 million Palindrome and Mahurkar Hemodialysis Catheters due to a defect that could cause serious injury…
Headline
Smiths Medical recently recalled more than 118,000 Medfusion syringe infusion pumps whose software could malfunction, causing serious patient harm or death,…
Headline
GE Healthcare is recalling 4,222 backup batteries for its CARESCAPE R860 ventilator in the United States because the batteries may fail before expected,…